Rexford S. Ahima

Professor
Medicine - Endocrinology, Diabetes and Metabolism
Johns Hopkins University
United States of America

Biography

Dr. Ahima is the Director of the Division of Endocrinology, Diabetes and Metabolism, Bloomberg Distinguished Professor of Diabetes in the Schools of Medicine, Public Health and Nursing, and the leader of the Johns Hopkins Diabetes Initiative. Dr. Ahima received his intercalated BSc research training in Endocrinology in the Middlesex Hospital Medical School, University of London, MD from the University of Ghana, and PhD from Tulane University in New Orleans, Louisiana. After completing his internship and residency training in Internal Medicine at the Albert Einstein College of Medicine, Jack D. Weiler Hospital and Jacobi Medical Center in New York, Dr. Ahima did his clinical and research fellowship training in Endocrinology, Diabetes and Metabolism at the Beth Israel Deaconess Medical Center and Harvard Medical School in Boston. Dr. Ahima is an elected member of the American Society for Clinical Investigation (ASCI), and the Association of American Physicians (AAP), and a fellow of the American College of Physicians (ACP), the Obesity Society (TOS), and the American Association for the Advancement of Science (AAAS). Dr. Ahima is an editor of the Annals of the New York Academy of Sciences Year in Diabetes and Obesity, and Molecular Endocrinology, and a member of the National Institute of Diabetes and Digestive and Kidney Diseases Clinical Obesity Research Panel. Dr. Ahima’s research on the pathogenesis of obesity and diabetes, particularly how adipokines, cytokines, myokines and other circulating factors target the brain and peripheral organs to control feeding and metabolism.

Research Intrest

pathogenesis of obesity and diabetes, particularly how adipokines, cytokines, myokines and other circulating factors target the brain and peripheral organs to control feeding and metabolism

List of Publications
Roat R, Rao V, Doliba NM, Matschinsky FM, Tobias JW, Garcia E, Ahima RS, Imai Y. Alterations of pancreatic islet structure, metabolism and gene expression in diet-induced obese C57BL/6J mice. Plos One. 9: e86815.
Carr RM, Peralta G, Yin X, Ahima RS. Absence of perilipin 2 prevents hepatic steatosis, glucose intolerance and ceramide accumulation in alcohol-fed mice. Plos One. 9: e97118.
Bang S, Chen Y, Ahima RS, Kim SF. Convergence of IPMK and LKB1-AMPK signaling pathways on metformin action. Molecular Endocrinology (Baltimore, Md.). 28: 1186-93.
homas SJ, Sarver JJ, Yannascoli SM, Tucker JJ, Kelly JD, Ahima RS, Barbe MF, Soslowsky LJ. Effect of isolated hyperglycemia on native mechanical and biologic shoulder joint properties in a rat model. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 32: 1464-70.
Carr RM, Dhir R, Mahadev K, Comerford M, Chalasani NP, Ahima RS. Perilipin staining distinguishes between steatosis and non-alcoholic steatohepatitis in adults and children. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.